NCT05388006 2025-10-14Acalabrutinib, Venetoclax and Durvalumab for the Treatment of Richter Transformation From Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaMayo ClinicPhase 2 Recruiting27 enrolled
NCT03011814 2025-09-18Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell LymphomaCity of Hope Medical CenterPhase 1/2 Active not recruiting38 enrolled